Valuation: Albert David Limited

Market Cap 394.94Cr 4.1Cr 3.6Cr 3.35Cr 3.07Cr 5.78Cr 5.86Cr 40Cr 16Cr 194.16Cr 15Cr 15Cr 671.33Cr P/E 2025
26.9x
P/E 2026 -224x
Enterprise Value 166.93Cr 1.73Cr 1.52Cr 1.42Cr 1.3Cr 2.44Cr 2.48Cr 17Cr 6.57Cr 82Cr 6.51Cr 6.37Cr 283.76Cr EV / Sales 2025
0.67x
EV / Sales 2026 0.32x
Free-Float
35.96%
Yield 2025
0.62%
Yield 2026 0.85%
1 day+2.17%
1 week-0.28%
Current month-0.13%
1 month-1.67%
3 months+0.15%
6 months+1.25%
Current year-5.19%
1 week 678
Extreme 678
705
1 month 678
Extreme 678
723
Current year 579.9
Extreme 579.9
819.6
1 year 579.9
Extreme 579.9
918.8
3 years 579.9
Extreme 579.9
1,753.95
5 years 486.85
Extreme 486.85
1,753.95
10 years 263
Extreme 263
1,753.95
Manager TitleAgeSince
Chief Executive Officer 52 12/05/2026
Director of Finance/CFO - 01/12/2020
Chief Tech/Sci/R&D Officer - -
Director TitleAgeSince
Director/Board Member 63 14/11/2024
Chairman 73 30/12/2009
Director/Board Member 68 31/03/2014
Change 5-day change 1-year change 3-year change Capi.($)
+2.17%-0.28% - - 4.1Cr
-0.66%+0.44%+14.72%+76.40% 4.84TCr
+2.20%+1.41%+61.04%+111.43% 3.58TCr
+1.26%-0.57%-5.20%+34.48% 1.18TCr
-0.46%-3.06%+14.15%+80.63% 1.15TCr
-0.37%-0.37%+37.89%+137.78% 901.45Cr
+1.52%+0.39%+48.79%-5.82% 698.99Cr
-0.17%-2.92%+13.13%+30.45% 669.73Cr
-0.59%-1.95%+2.23%+178.07% 642.34Cr
-7.92%-13.61%-34.97%-4.08% 529.99Cr
Average -0.30%-2.12%+16.87%+71.04% 1.58TCr
Weighted average by Cap. +0.12%-0.45%+25.35%+81.36%

Financials

2025 2026
Net sales 345.77Cr 3.59Cr 3.15Cr 2.93Cr 2.69Cr 5.06Cr 5.13Cr 35Cr 14Cr 169.99Cr 13Cr 13Cr 587.75Cr 333.6Cr 3.46Cr 3.04Cr 2.83Cr 2.6Cr 4.88Cr 4.95Cr 34Cr 13Cr 164.01Cr 13Cr 13Cr 567.06Cr
Net income 17Cr 17.86L 15.69L 14.59L 13.39L 25.15L 25.54L 1.73Cr 67.68L 8.46Cr 67.05L 65.61L 29Cr -1.49Cr -2L -1L -1L -1L -2L -2L -15.05L -6L -73.48L -6L -6L -2.54Cr
Net Debt -231.34Cr -2.4Cr -2.11Cr -1.96Cr -1.8Cr -3.38Cr -3.44Cr -23Cr -9.1Cr -113.73Cr -9.02Cr -8.82Cr -393.24Cr -228Cr -2.37Cr -2.08Cr -1.93Cr -1.77Cr -3.33Cr -3.39Cr -23Cr -8.97Cr -112.09Cr -8.89Cr -8.7Cr -387.57Cr
Logo Albert David Limited
Albert David Limited is an India-based pharmaceutical company. The Company's principal business is manufacturing and trading of pharmaceutical formulations, infusion solutions, herbal dosage forms and bulk drugs by way of domestic sale or export. Its product categories include formulations and bulk drugs. Its product range includes Placentrex range, Anaflam range and BREAZE range. Its formulations include parenteral, oral/enteral, topical agents and vision care. Its parenteral categories include amino acids infusion, anti-microbial, anti-leishmaniasis (kalazar), haemostat (inj), lvp, neurotropic vitamin and placenta extract. The Company's oral/enteral categories include amino acids oral, anthelmintic, anti-microbial, anti-ulcer ants, anti-vertigo, appetite stimulants, anti-tubercular, expectorant / cough syrup, hematinic, haemostat, hepato protective (ayurveda) and hepato protective (others). Its vision care categories include anti glaucoma, anti-infective and NSAID.
Employees
1,476
Date Price Change Volume
24/26/24 ₹698.35 +2.17% 1,133
23/26/23 ₹683.55 -0.57% 3,881
22/26/22 ₹687.50 -1.26% 1,652
21/26/21 ₹696.30 -0.24% 2,337
20/26/20 ₹698.00 -0.33% 4,064